Not written in this tone yet.

The reports

#ReportOutletDate
1UK regulator brings new AI and MedTech agenda to AdvaMed

UK’s Medicines and Healthcare products Regulatory Agency (MHRA) sets out its next phase of MedTech and AI regulation to US industry leaders at AdvaMed 2026.

GOV.UK news and announcements
2MHRA authorises plozasiran (Redemplo) for adults with familial chylomicronaemia syndrome

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 19 October 2026, authorised plozasiran (Redemplo)

GOV.UK news and announcements

All AI briefs · Live · The wire